INEGY 10/20 Milligram Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

inegy 10/20 milligram tablets

merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/20 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

INEGY 10/80 Milligram Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

inegy 10/80 milligram tablets

merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/80 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

INEGY 10/10 Milligram Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

inegy 10/10 milligram tablets

merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/10 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

INEGY 10/40 Milligram Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

inegy 10/40 milligram tablets

merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/40 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

EZETIMIBE/SIMVASTATIN 10/20 Milligram Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

ezetimibe/simvastatin 10/20 milligram tablets

actavis group hf - ezetimibe, simvastatin - tablets - 10/20 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

EZETIMIBE/SIMVASTATIN 10/40 Milligram Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

ezetimibe/simvastatin 10/40 milligram tablets

actavis group hf - ezetimibe, simvastatin - tablets - 10/40 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

EZETIMIBE/SIMVASTATIN 10/80 Milligram Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

ezetimibe/simvastatin 10/80 milligram tablets

actavis group hf - ezetimibe, simvastatin - tablets - 10/80 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents